Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
about
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionAnti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusionRole of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trialsCentral Retinal Vein Occlusion: A Review of Current Evidence-based Treatment OptionsClinical Trials in Branch Retinal Vein OcclusionSteroids in Central Retinal Vein Occlusion: Is There a Role in Current Treatment Practice?The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacyAdvances in drug delivery to the posterior segmentComparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone AcetonideDexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trialIntense exercise causing central retinal vein occlusion in a young patient: case report and review of the literature.Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis.Evaluation of pain during intravitreal Ozurdex injections vs. intravitreal bevacizumab injections.Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.Single compartment drug delivery.Repeated treatment for macular edema in vein occlusion by intravitreal implant of dexamethasone.Retinal and choroidal thickness measurements using spectral domain optical coherence tomography in anterior and intermediate uveitisIntravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion.Impact on intraocular pressure after 20-mg decanted triamcinolone acetonide (kenalog) injection when using prophylactic antiglaucoma therapy.Branch retinal vein occlusion: treatment modalities: an update of the literature.Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.The ABCs of RVO: a review of retinal venous occlusion.Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1).Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusionRanibizumab in retinal vein occlusion: treatment recommendations by an expert panelBaseline predictors of visual acuity and retinal thickness in patients with retinal vein occlusionPharmacotherapy for treatment of retinal vein occlusion.Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trialsComparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis.[Retinal vein occlusion: Therapy of retinal vein occlusion].Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective studyTwo or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.Retrospective analyses of optical coherence tomography in recurrent macular edema following intravitreal therapy in patients with retinal vein occlusionIntravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials.Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusionA prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.
P2860
Q24187275-C83424B4-7633-4F7B-ACBB-00280C74F6F0Q24194783-5C4AEDFB-9B09-4641-A4F6-62EFB84301ECQ26750459-8091670F-1A5A-4CDB-981D-1061BC986B71Q26767089-696FFF4F-55E1-4009-BE05-86580BDD753FQ26767092-9C60CB1B-A9AE-4CF5-85C5-9BBFE812EB72Q26774524-FA2EC93E-2CCE-497A-9AD9-159830FCE5CCQ26849299-E2C0A2BC-4E3C-4F96-9E4F-6F9EFED0BA4EQ26995920-AEA2AAB9-7211-48B3-AA04-13C9F11D4B9AQ28383760-C4A78159-CBC4-4B53-8839-9467730F9629Q31117687-E546E2C6-CAB3-4A53-BD10-27CFDBF94241Q33628064-F0A4EDD4-DCFD-472B-A492-0672495B9194Q33995887-2D1CA931-F921-4273-8294-B24DBBF4D58AQ34055040-79386908-24D6-4F1A-99FE-C3F3D0E81AD1Q34238856-B71DE87B-4BF3-453F-83E8-7EAB61F931D5Q34263907-4CEFDB2E-905D-4A6B-8DB0-098C1B4C28B7Q34471740-E94B7B70-29D3-4F68-A8CD-20A93AF5850BQ34538702-69BBA35B-16F6-4D21-9FC4-FAE4846C155FQ34657063-E51E009C-CA35-435D-8972-2F3827BEF959Q34708262-865C313F-D8DF-4AC7-96BF-53BDEDEEA8C6Q34771834-60E7273B-E3BD-4B1E-AF7A-1021F2D5C6E9Q35028773-C8533483-3F70-482D-A1A6-F632BF8B16E5Q35030923-353F9F87-5ABB-4F33-8827-2F3992C814CEQ35036495-4F1318D5-0B35-48AA-9B2D-94DDA9A58B87Q35047634-C3F9A7FC-84FA-4548-BE9C-9BD86582BF44Q35079688-B766528C-C9A3-4639-BB1B-FA370B3050F7Q35087987-637F7AC1-A6AE-495C-8A9C-191D7E9FE282Q35135745-AC45E4AB-5486-432A-B719-CA31602706ABQ35198601-3FA2AA0E-416F-4B66-9EC2-AEFCFC787839Q35238943-287EFF30-521D-4DA5-9BBA-4C577EECC645Q35336651-CE7B284F-FF33-4582-A510-06A652C33968Q35594036-2CC81015-7734-4A6B-8709-073D5ECFA15CQ35655005-8236EDC4-1E01-4675-8130-8BFBDC1087CCQ35737854-95E81D8C-89CB-43C5-93EA-09CA8E72369DQ35748981-21B86F79-DF9C-4BB4-A943-53F9AEDBF369Q35764068-218B9DC1-12A7-4BCC-8320-D557ECC7426FQ35764081-C928B648-8744-456C-8E31-085ECA77BB5BQ35769968-637AD113-7348-45B4-85DD-3AC88F74D046Q35794470-F73D070C-A76B-4A8D-812C-B3899F615A85Q35809696-474FCB54-7BC6-48A2-BFC1-F02824978E60Q35862168-329C21E7-F74D-4E3B-9026-7378FCFA47B3
P2860
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dexamethasone intravitreal imp ...... on twelve-month study results.
@ast
Dexamethasone intravitreal imp ...... on twelve-month study results.
@en
Dexamethasone intravitreal imp ...... on twelve-month study results.
@nl
type
label
Dexamethasone intravitreal imp ...... on twelve-month study results.
@ast
Dexamethasone intravitreal imp ...... on twelve-month study results.
@en
Dexamethasone intravitreal imp ...... on twelve-month study results.
@nl
prefLabel
Dexamethasone intravitreal imp ...... on twelve-month study results.
@ast
Dexamethasone intravitreal imp ...... on twelve-month study results.
@en
Dexamethasone intravitreal imp ...... on twelve-month study results.
@nl
P2093
P1433
P1476
Dexamethasone intravitreal imp ...... on twelve-month study results.
@en
P2093
Anat Loewenstein
Jeffrey Heier
Jenny Jiao
Julia A Haller
Mark Gillies
Mark S Blumenkranz
Ozurdex GENEVA Study Group
Rubens Belfort
Xiao-Yan Li
P304
P356
10.1016/J.OPHTHA.2011.05.014
P577
2011-07-20T00:00:00Z